AstraZeneca will pay $420 million to Moderna Therapeutics in a deal to develop drugs for a variety of diseases using a technology developed by Moderna, AstraZeneca said.
Drug maker GlaxoSmithKline's philanthropic arm has donated $500,000 to the Children's Hospital of Philadelphia as part of a fund that provides assistance to families for travel and living expenses they may incur while their children are enrolled in experimental or novel treatments offered at the hospital's Cancer Center.
The Food and Drug Administration has approved a new pocket-sized packet option for a testosterone-replacement therapy made by AbbVie, the drug maker said Friday.
The Food and Drug Administration will decide in late August whether to approve an experimental opioid painkiller made by QRxPharma, the drug maker said Thursday.
The attorneys general of 46 states and two territories are calling on the Food and Drug Administration to make prescription painkillers harder to abuse.
While the country's spending on specialty drugs increased by 18.4% in 2012, spending on traditional drugs fell for the first time in 20 years, according to a report by Express Scripts.
A new bill (HB 365) in Florida's state legislature would allow pharmacists to substitute biosimilars for branded biotech drugs, according to published reports.
Drug maker Merck has hired celebrity chef and cookbook author Leticia Moreinos Schwartz as a spokeswoman to reach out to Hispanics living with Type 2 diabetes, the drug maker said.
Global warming could spell the end of flu seasons, research released by the National Institution of Health suggests, because the influenza virus better propagates and is more sustainable in colder climates.
Employers that use multiple cost-management programs have a 50% lower specialty drug trend than those that don't use them, according to a new study by pharmacy benefit manager Express Scripts.
Several senators have requested that the Government Accountability Office look for ways to coordinate the efforts of law enforcement and public health agencies at various levels and nonprofit organizations to address prescription drug abuse.
The Centers for Disease Control and Prevention set the stage for the first quadrivalent influenza vaccine to be introduced in the 2013-2014 flu season, according to a report in The Wall Street Journal.
The Supreme Court will hear arguments later this month in a case that could determine the future of many patent settlements between brand and generic drug makers.
A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan Corp., but hasn't heard back from it, according to published reports.
The proportion of outpatient visits for influenza-like illness was 2.8% for the week ended Feb. 16, the Centers for Disease Control and Prevention reported Friday, a strong indicator that the 2012-2013 flu season is on its way out.